|本期目录/Table of Contents|

[1]王笑寒,张小林,张保朝.比较rt-PA单独或联合肝素钠对急性缺血性脑卒中神经功能和氧化应激水平的影响[J].天津医科大学学报,2021,27(06):628-631,636.
　WANG Xiao-han,ZHANG Xiao-lin,ZHANG Bao-chao.Comparison of the effects of rt-PA alone or combined with heparin sodium on neurological function and oxidative stress levels in acute ischemic stroke[J].Journal of Tianjin Medical University,2021,27(06):628-631,636.
点击复制

比较rt-PA单独或联合肝素钠对急性缺血性脑卒中神经功能和氧化应激水平的影响(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27卷
期数:
2021年06期
页码:
628-631,636
栏目:
临床医学
出版日期:
2021-11-15

文章信息/Info

Title:
Comparison of the effects of rt-PA alone or combined with heparin sodium on neurological function and oxidative stress levels in acute ischemic stroke
文章编号:
1006-8147（2021）06-0628-04
作者:
王笑寒; 张小林; 张保朝
（南阳市中心医院神经内科，南阳473000）
Author(s):
WANG Xiao-han; ZHANG Xiao-lin; ZHANG Bao-chao
（Department of Neurology，Nanyang Central Hospital，Nanyang 473000，China）
关键词:
急性缺血性脑卒中; rt-PA; 肝素钠; 氧化应激相关因子; 神经功能
Keywords:
acute cerebral infarction; rt-PA; heparin sodium; oxidative stress-related factors; nerve function
分类号:
R743.33
DOI:
-
文献标志码:
A
摘要:
目的：比较阿替普酶（rt-PA）单独或联合肝素钠治疗急性缺血性脑卒中对神经功能和氧化应激水平变化的影响。方法：收集2018年1月—2020年5月接受治疗的急性缺血性脑卒中患者126例。根据治疗方案的不同将患者分为对照组（rt-PA治疗，52例），观察组（rt-PA联合肝素钠治疗，74例）。分析两组患者治疗后的总有效率、氧化应激指标变化、神经功能指标变化、神经功能良好转归率和不良反应发生率。结果：与对照组（71.2%）相比，观察组总有效率为89.2%（χ2=6.657，P=0.010）。治疗后，与对照组相比，观察组超氧化物歧化酶（SOD）和谷胱甘肽过氧化物酶（GSH-px）水平升高（t=3.041，P=0.039；t=8.105，P<0.001），丙二醛（MDA）和氧化型低密度脂蛋白（ox-LDL）的水平降低（t=4.150，P=0.009；t=10.207，P<0.001）；美国国立卫生研究院卒中量表（NIHSS ）评分和S100B（S100钙结合蛋白B）蛋白水平降低（t=5.414，P<0.001；t=3.115，P=0.031），脑源性神经营养因子（BDNF）水平升高（t=3.052，P=0.041）；改良Rankin量表（mRS）评分降低（t=3.043，P=0.045）。与对照组相比，观察组神经功能转归良好率较高（χ2=4.090，P=0.043），不良反应率差异无统计学意义（P>0.05）。结论：rt-PA联合肝素钠与rt-PA单独治疗急性缺血性脑卒中相比，临床疗效显著，可有效改善氧化应激指标水平和神经功能，且未增加患者的不良反应。
Abstract:
Objective： To compare the effects of alteplase（rt-PA） alone or combined with heparin sodium on the changes of nerve function and oxidative stress in the treatment of acute ischemic stroke. Methods： A total of 126 patients with acute cerebral infarction who were treated in Nanyang Central Hospital from January 2018 to May 2020 were collected. Patients were divided into control group（rt-PA treatment，52 cases） and observation group（rt-PA combined with heparin sodium treatment，74 cases） according to different treatment options. The total effective rate，changes in oxidative stress indexes，changes in neurological function indexes，good neurological function outcomes and incidence of adverse reactions were analyzed after treatment in both groups. Results：Compared with the control group（71.2%），the total effective rate of the observation group was 89.2%（χ2=6.657，P=0.010）. After treatment，compared with the control group，the levels of superoxide dismutase（SOD） and glutathione peroxidase（GSH-px） in the observation group increased（t=3.041，P=0.039；t=8.105，P<0.001），the levels of malondialdehyde（MDA） and oxidized low-density lipoprotein（ox-LDL） decreased（t=4.150，P=0.009；t=10.207，P<0.001），the National Institutes of Health Stroke Scale（NIHSS） score and S100B （S100 calcium binding protein B） protein levels decreased（t=5.414，P<0.001；t=3.115，P=0.031），brain-derived neurotrophic factor（BDNF） level increased（t=3.052，P=0.041），modified Rankin Scale （mRS） score decreased（t=3.043，P=0.045）. Compared with the control group，the observation group had a higher neurological function outcome rate（χ2=4.090，P=0.043），and the difference in the adverse reaction rate was not statistically significant（P>0.05）. Conclusion： Compared with rt-PA in the treatment of acute cerebral infarction，rt-PA combined with heparin sodium has a significant clinical effect，which can effectively improve the level of oxidative stress indicators and nerve function，and does not increase the adverse reactions of patients.

参考文献/References:

[1] GBD 2013 MORTALITY AND CAUSES OF DEATH COLLABORATORS. Global，regional，and national age-sex specific all-cause and causespecific mortality for 240 causes of death，1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet，2015，385（9963）：117
[2] ZHOU M，WANG H，ZHU J，et al. Cause-specific mortality for 240 causes in China during 1990-2013： a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet，2016， 387（10015）：251
[3] O′GARA P T，KUSHNER F G，ASCHEIM D D，et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction：a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol，2013，61（4）：e78
[4] LI J，LI X，WANG Q，et al. ST-segment elevation myocardial infarction in China from 2001 to 2011（the China PEACE-Retrospective Acute Myocardial Infarction Study）： a retrospective analysis of hospital data[J]. Lancet，2015，385（9966）：441
[5] VIIKIL?魧 J，LILLEBERG J，TIERALA I，et al. Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction： the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction（HUS-STEMI）[J]. Eur Heart J Acute Cardiovasc Care，2013，2（4）：371
[6] TAYLOR J. 2012 ESC Guidelines on acute myocardial infarction （STEMI）[J]. Eur Heart J，2012,33（20）：2501
[7] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志，2018，51（9）：666
[8] KWAH L K,DIONG J. Nalional institutes of health stroke scale （NIHss）[J]． J Physioth，2014，60（1）：61
[9] SABER H，THRIFT A G，KAPRAL M K，et al. Incidence，recurrence，and long-term survival of ischemic stroke subtypes： a population-based study in the Middle East[J]. Int J Stroke，2017,12（8）：835
[10] WANG W，JIANG B,SUN H，et al. Prevalence，incidence，and mortality of stroke in China：results from a nationwide population-based survey of 480 687 adults[J]. Circulation,2017,13 5（8）：759
[11] YANG P，ZHANG Y，ZHANG L，et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke[J].N Engl J Med，2020,382（21）：1981
[12] TORRES H，RIVERA M，GARCIA L. Complete cognitive recovery and survival from massive pulmonary embolism during general anesthesia after administration of alteplase： a case report[J]. P R Health Sci J，2020,39（1）：62
[13] DAS S，MONDAL G P，BHATTACHARYA R，et al. Predictors of postthrombolysis outcome and symptomatic postthrombolysis hemorrhage following intravenous thrombolysis with alteplase for acute ischemic stroke[J]. J Neurosci Rural Pract，2020，11（2）：315
[14] SYAFRITA Y，AMIR D，SUSANTI R，et al. Relationship of brain-derived neurotrophic factor，malondialdehyde，and 8-Hydroxy 2-Deoxyguanosine with post-ischemic stroke depression[J]. Dement Neuropsychol，2020,14（1）：41
[15] MILANLIOGLU A，ASLAN M，OZKOL H，et al. Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke： influence on neurological status and outcome[J]. Wien Klin Wochenschr，2016,128（5/6）：169
[16] JIANG F，XU X R，LI W M，et al. Monotropein alleviates H2O2 induced inflammation，oxidative stress and apoptosis via NF-κB/AP-1 signaling[J]. Mol Med Rep，2020,22（6）： 4828
[17] WU L，FENG Q，AI M L，et al. The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy[J].Sci Rep，2020,10（1）：7718
[18] LI C H，CHEN Y，ZHANG C H，et al. Observation of clinical efficacy of rt-PA intravenous thrombolytic treatment for patients combined with grade 0-1 diabetic foot by Wagner classification and acute ischemic stroke [J]. Eur Rev Med Pharmacol Sci，2016，20（24）：5168

相似文献/References:

备注/Memo

备注/Memo:
基金项目 河南省医学科技攻关计划（2018020174） 作者简介 王笑寒(1988-)，女，主治医师，硕士，研究方向：脑血管病; E-mail: huangjingg123@163.com。
更新日期/Last Update: 2021-11-15